Why is Mankind Pharma falling/rising?

As of 19-Sep, Mankind Pharma Ltd's stock price is currently at 2,660.00, reflecting an increase of 25.0 (0.95%). The stock has been gaining momentum, having outperformed its sector by 0.68% today and achieving a consecutive gain over the last two days with a total return of 3.67%. Additionally, Mankind Pharma is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend. The stock has also shown impressive performance over the past week and month, with returns of +2.96% and +6.77%, respectively, while it has managed to generate a 9.25% return over the past year despite the broader market's negative performance. Factors contributing to this positive movement include high management efficiency, a low debt-to-equity ratio, and healthy long-term growth in net sales and operating profit, alongside significant institutional holdings.
In the broader market context, Mankind Pharma's recent performance stands out as it has outpaced the benchmark Sensex, which has only returned +0.88% over the same week. This indicates that the stock is not only resilient but also gaining traction in a market that has seen negative returns over the past year. The stock's ability to generate positive returns while the BSE500 index has declined by -1.96% further underscores its strong market position and investor confidence, suggesting that the recent price rise is supported by solid fundamentals and increasing investor participation.